Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Batra RN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Batra RN; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.; German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany., Lifshitz A; Department of Computer Science and Applied Mathematics, and Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Vidakovic AT; Mechanisms of Transcription Laboratory, The Francis Crick Institute, London, UK., Chin SF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Sati-Batra A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Sammut SJ; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, Cambridge, UK.; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Provenzano E; Cancer Research UK Cambridge Centre, Cambridge, UK.; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Ali HR; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, Cambridge, UK.; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dariush A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Bruna A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Murphy L; Research Institute in Oncology and Hematology, Winnipeg, Manitoba, Canada., Purushotham A; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ellis I; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Green A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Garrett-Bakelman FE; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA., Mason C; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Melnick A; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Aparicio SAJR; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada., Rueda OM; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Tanay A; Department of Computer Science and Applied Mathematics, and Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. amos.tanay@weizmann.ac.il., Caldas C; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. Carlos.Caldas@cruk.cam.ac.uk.; Department of Oncology, University of Cambridge, Cambridge, UK. Carlos.Caldas@cruk.cam.ac.uk.; Cancer Research UK Cambridge Centre, Cambridge, UK. Carlos.Caldas@cruk.cam.ac.uk.; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Carlos.Caldas@cruk.cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Sep 13; Vol. 12 (1), pp. 5406. Date of Electronic Publication: 2021 Sep 13.
Autor:
Uribe ML; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Dahlhoff M; Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, 1210 Vienna, Austria., Batra RN; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Nataraj NB; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Haga Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan., Drago-Garcia D; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Marrocco I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Sekar A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Ghosh S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Vaknin I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Lebon S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Kramarski L; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel., Tsutsumi Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.; Global Center for Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan., Choi I; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 306-809, South Korea., Rueda OM; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK.; MRC Biostatistics Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0RE, UK., Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. yosef.yarden@weizmann.ac.il.
Publikováno v:
Science signaling [Sci Signal] 2021 Jun 22; Vol. 14 (688). Date of Electronic Publication: 2021 Jun 22.
Autor:
Mayakonda A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany., Schönung M; Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany.; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany.; German-Israeli Helmholtz Research School in Cancer Biology, partner site Heidelberg, Germany., Batra RN; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Feuerstein-Akgoz C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69117 Heidelberg, Germany., Köhler K; Bioinformatics Bachelor Program, Free University Berlin, 14195 Berlin, Germany., Lipka DB; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Sotillo R; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Research Consortium (DKTK), partner site Heidelberg, Germany., Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Toth R; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2021 Apr 01; Vol. 36 (22-23), pp. 5524-5525.
Autor:
Sanchez-Santos MT; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Arthritis research UK Centre for Sport, Exercise and Osteoarthritis, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Garriga C; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. cesar.garriga-fuentes@ndorms.ox.ac.uk., Judge A; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK., Batra RN; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Price AJ; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Liddle AD; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Javaid MK; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK., Cooper C; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK., Murray DW; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Arden NK; Musculoskeletal Epidemiology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Publikováno v:
Scientific reports [Sci Rep] 2018 Feb 21; Vol. 8 (1), pp. 3381. Date of Electronic Publication: 2018 Feb 21.
Autor:
Callari M; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Batra AS; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Batra RN; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Sammut SJ; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Greenwood W; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Clifford H; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Hercus C; Novocraft Technologies Sdn Bhd, C-23A-05, 3 Two Square, Jalan 19/1, Section 19, 46300, Petaling Jaya, Selangor Darul Ehsan, Malaysia., Chin SF; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Bruna A; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Rueda OM; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Caldas C; CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. carlos.caldas@cruk.cam.ac.uk.
Publikováno v:
BMC genomics [BMC Genomics] 2018 Jan 05; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2018 Jan 05.
Autor:
Polak P; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Kim J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Braunstein LZ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Karlic R; Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia., Haradhavala NJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA., Tiao G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Livitz D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Kübler K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Mouw KW; Harvard Medical School, Boston, Massachusetts, USA.; Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kamburov A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Maruvka YE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Lander ES; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Biology, MIT, Cambridge, Massachusetts, USA.; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zick A; Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Orthwein A; Department of Oncology, McGill University, Montreal, Quebec, Canada., Lawrence MS; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Batra RN; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK.; Cancer Research UK Cambridge Centre, Cambridge, UK.; Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK.; Cancer Research UK Cambridge Centre, Cambridge, UK.; Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK., Haber DA; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Laird PW; Van Andel Research Institute, Grand Rapids, Michigan, USA., Shen H; Van Andel Research Institute, Grand Rapids, Michigan, USA., Ellisen LW; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., D'Andrea AD; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA., Foulkes WD; Department of Oncology, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Publikováno v:
Nature genetics [Nat Genet] 2017 Oct; Vol. 49 (10), pp. 1476-1486. Date of Electronic Publication: 2017 Aug 21.
Autor:
Bruna A; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Rueda OM; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Greenwood W; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Batra AS; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Callari M; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Batra RN; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Pogrebniak K; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Sandoval J; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Cassidy JW; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Tufegdzic-Vidakovic A; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Sammut SJ; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Jones L; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK., Provenzano E; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK., Baird R; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK., Eirew P; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada., Hadfield J; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., Eldridge M; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK., McLaren-Douglas A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Barthorpe A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Lightfoot H; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., O'Connor MJ; DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK., Gray J; OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA., Cortes J; Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain., Baselga J; Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA., Marangoni E; Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France., Welm AL; Huntsman Cancer Institute, Salt Lake City, UT 84112, USA., Aparicio S; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada., Serra V; Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain., Garnett MJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: carlos.caldas@cruk.cam.ac.uk.
Publikováno v:
Cell [Cell] 2016 Sep 22; Vol. 167 (1), pp. 260-274.e22. Date of Electronic Publication: 2016 Sep 15.
Autor:
Thomas GE; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK. Electronic address: geraint.thomas@ndorms.ox.ac.uk., Palmer AJ; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Batra RN; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Kiran A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Hart D; Department of Twin Research & Genetic Epidemiology, King's College London, St Thomas' Hospital Campus, 3rd & 4th Floor South Wing Block D, Westminster Bridge Road, London SE1 7EH, UK., Spector T; Department of Twin Research & Genetic Epidemiology, King's College London, St Thomas' Hospital Campus, 3rd & 4th Floor South Wing Block D, Westminster Bridge Road, London SE1 7EH, UK., Javaid MK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Judge A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Murray DW; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Carr AJ; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK., Arden NK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK., Glyn-Jones S; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK.
Publikováno v:
Osteoarthritis and cartilage [Osteoarthritis Cartilage] 2014 Oct; Vol. 22 (10), pp. 1504-10. Date of Electronic Publication: 2014 Jul 15.